Overview
Compare with Charming Medical Ltd, NewGenIvf Group Ltd or Marpai, Inc., or pick any stock.
- TickerPFHO on OTC2
- IndustryServices-Misc Health & Allied Services, NEC2
- HeadquartersNewport Beach, United States2
- Incorporated inUT3
- Business address19800 Macarthur Boulevard, Suites 306 & 307, Irvine, Ca 926123
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formProfit Corporation2
- LEI549300TVZWVLR3MFHI132
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressC/O NATIONAL REGISTERED AGENTS, INC., 84047 Midvale, United States2
- Registered withUtah Division of Corporations & Commercial Code (Department of Commerce), 613952-01422
See how the biggest companies compare on our leaderboards
Our services focus on ensuring timely medical treatment to reduce the claim duration and medical treatment costs.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Medical Case Management brought in 33% of the revenue PACIFIC HEALTH CARE ORGANIZATION INC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Medical Case Management | $1.6M | $2.2M |
| Utilization Review | $2.1M | $2.2M |
| HCOMember | $1.2M | $1.2M |
| MPNMember | $625.5K | $663.5K |
| Medical Bill Review | $418.3K | $403.3K |
| Other Revenues | $151.7K | $45.2K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs72¢$4.8M
- Interest0¢$1.5K
- Income tax8¢$507.1K
- Profit21¢$1.4M
Out of $6.7M in revenue.5
Where each dollar of operating cash went, fiscal 2025
- Capital spending2¢$23.3K
- Dividends paid3¢$37.0K
- Kept or used elsewhere95¢$1.1M
Out of $1.2M of cash from operations.5
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $6.7M | $6.1M |
| Salaries and wages | $2.7M | $2.8M |
| Professional fees | $931.2K | $600.9K |
| Insurance | $332.6K | $332.9K |
| Outsource service fees | $736.0K | $699.1K |
| Data maintenance | $210.9K | $91.4K |
| General and administrative | $767.0K | $726.3K |
| Total expenses | $5.7M | $5.2M |
| Income from operations | $1.0M | $852.6K |
| Other income (Note 14) | $421.7K | $0 |
| Interest income | $473.6K | $414.6K |
| Interest expense | -$1.5K | -$3.6K |
| Total other income, net | $893.8K | $411.1K |
| Income before taxes | $1.9M | $1.3M |
| Income tax provision | $507.1K | $380.1K |
| Net income | $1.4M | $883.6K |
| Net Income per share amount (in Dollars per share) | $0.11 | $0.07 |
| Weighted average shares outstanding, basic (in Shares) | 12.8M shares | 12.8M shares |
| Net Income per share amount (in Dollars per share) | $0.11 | $0.07 |
| Weighted average shares outstanding, diluted (in Shares) | 12.8M shares | 12.8M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $2.2M | $2.1M | |
| Investments | $10.0M | $9.0M | |
| Accounts receivable, net | $1.0M | $1.0M | |
| Prepaid expenses | $157.5K | $202.1K | |
| Income tax receivable | $13.3K | $0 | |
| Total current assets | $13.4M | $12.3M | |
| Property and equipment, net | $51.7K | $52.4K | |
| Deferred tax assets | $16.2K | $38.0K | |
| Other assets | $7.5K | $7.1K | |
| Total long-term assets | $75.4K | $97.5K | |
| Total Assets | $13.5M | $12.4M | |
| Accounts payable | $228.0K | $148.1K | |
| Accrued expenses | $127.0K | $423.0K | |
| Income tax payable | $0 | $68.7K | |
| Dividend payable | $0 | $37.0K | |
| Insurance financing | $0 | $35.3K | |
| Unearned revenue | $33.5K | $33.5K | |
| Total Current Liabilities | $388.6K | $745.6K | |
| Convertible Preferred stock; 5,000,000 shares authorized at $0.001 par value of which 40,000 shares designated as Series A preferred and 16,000 shares issued and outstanding at December 31, 2025 and 2024 | $16 | $16 | |
| Common stock, $0.001 par value, 800,000,000 shares authorized, 12,800,000 shares issued and outstanding at December 31, 2025 and 2024 | $12.8K | $12.8K | |
| Additional paid-in capital | $416.1K | $416.1K | |
| Retained earnings | $12.6M | $11.3M | |
| Total Stockholders Equity | $13.1M | $11.7M | $10.8M |
| Total Liabilities and Stockholders Equity | $13.5M | $12.4M | |
| Convertible Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Convertible Preferred stock, shares authorized (in Shares) | 5.0M shares | 5.0M shares | |
| Convertible Preferred stock, shares issued (in Shares) | 16.0K shares | 16.0K shares | |
| Convertible Preferred stock, shares outstanding (in Shares) | 16.0K shares | 16.0K shares | |
| Common stock par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares issued (in Shares) | 12.8M shares | 12.8M shares | |
| Common stock, outstanding (in Shares) | 12.8M shares | 12.8M shares | |
| Common stock, shares authorized (in Shares) | 800.0M shares | 800.0M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $2.2M | $2.1M | |
| Investments | $10.0M | $9.0M | |
| Accounts receivable, net | $1.0M | $1.0M | |
| Prepaid expenses | $157.5K | $202.1K | |
| Income tax receivable | $13.3K | $0 | |
| Total current assets | $13.4M | $12.3M | |
| Property and equipment, net | $51.7K | $52.4K | |
| Deferred tax assets | $16.2K | $38.0K | |
| Other assets | $7.5K | $7.1K | |
| Total long-term assets | $75.4K | $97.5K | |
| Total Assets | $13.5M | $12.4M | |
| Accounts payable | $228.0K | $148.1K | |
| Accrued expenses | $127.0K | $423.0K | |
| Income tax payable | $0 | $68.7K | |
| Dividend payable | $0 | $37.0K | |
| Insurance financing | $0 | $35.3K | |
| Unearned revenue | $33.5K | $33.5K | |
| Total Current Liabilities | $388.6K | $745.6K | |
| Convertible Preferred stock; 5,000,000 shares authorized at $0.001 par value of which 40,000 shares designated as Series A preferred and 16,000 shares issued and outstanding at December 31, 2025 and 2024 | $16 | $16 | |
| Common stock, $0.001 par value, 800,000,000 shares authorized, 12,800,000 shares issued and outstanding at December 31, 2025 and 2024 | $12.8K | $12.8K | |
| Additional paid-in capital | $416.1K | $416.1K | |
| Retained earnings | $12.6M | $11.3M | |
| Total Stockholders Equity | $13.1M | $11.7M | $10.8M |
| Total Liabilities and Stockholders Equity | $13.5M | $12.4M | |
| Convertible Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | |
| Convertible Preferred stock, shares authorized (in Shares) | 5.0M shares | 5.0M shares | |
| Convertible Preferred stock, shares issued (in Shares) | 16.0K shares | 16.0K shares | |
| Convertible Preferred stock, shares outstanding (in Shares) | 16.0K shares | 16.0K shares | |
| Common stock par value (in Dollars per share) | $0.00 | $0.00 | |
| Common stock, shares issued (in Shares) | 12.8M shares | 12.8M shares | |
| Common stock, outstanding (in Shares) | 12.8M shares | 12.8M shares | |
| Common stock, shares authorized (in Shares) | 800.0M shares | 800.0M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income | $1.4M | $883.6K |
| Depreciation | $24.0K | $34.1K |
| Provision for credit losses | $9.4K | -$19.1K |
| Noncash interest on investments | -$42.2K | -$31.2K |
| Deferred taxes | $21.8K | $881 |
| Accounts receivable | $13.8K | $10.8K |
| Income tax receivable | -$13.3K | $0 |
| Other assets | -$382 | $0 |
| Prepaid expenses | $44.7K | -$22.4K |
| Accounts payable | $80.0K | -$11.7K |
| Accrued expenses | -$295.9K | $55.4K |
| Income tax payable | -$68.7K | -$227.7K |
| Unearned revenue | $0 | $2.6K |
| Net cash provided by operating activities | $1.2M | $675.1K |
| Proceeds from investments | $18.7M | $15.9M |
| Purchase of investments | -$19.7M | -$17.1M |
| Purchase of property and equipment | -$23.3K | -$9.1K |
| Net cash provided by (used in) investing activities | -$990.1K | -$1.1M |
| Escheatment of unclaimed cash dividends | -$37.0K | $0 |
| Proceeds from insurance financing agreement | $0 | $139.8K |
| Payments made on insurance financing agreement | -$35.3K | -$104.5K |
| Net cash provided by (used in) financing activities | -$72.3K | $35.3K |
| Net increase (decrease) in cash and cash equivalents | $98.3K | -$423.5K |
| Interest | $1.5K | $3.6K |
No quarter-by-quarter statement was filed.
Compare PACIFIC HEALTH CARE ORGANIZATION INC with another company
Corporate structure
PACIFIC HEALTH CARE ORGANIZATION INC sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of PACIFIC HEALTH CARE ORGANIZATION INC
- Tom Kubota Filed SCHEDULE 13D/A on PACIFIC HEALTH CARE ORGANIZATION INC, latest Jun 2, 2026 (4 filings since Dec 29, 2021)
- Bruce Everakes Filed SC 13G on PACIFIC HEALTH CARE ORGANIZATION INC, latest Apr 12, 2023
- PACIFIC HEALTH CARE ORGANIZATION INC Newport Beach, California, United States
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What PACIFIC HEALTH CARE ORGANIZATION INC reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Furniture and fixtures | $13.3K5 Dec 31, 2025 | $13.3K5 Dec 31, 2024 | 0% |
| Property and equipment, before depreciation | $281.1K5 Dec 31, 2025 | $257.8K5 Dec 31, 2024 | +9.0% |
| Accumulated depreciation | $229.4K5 Dec 31, 2025 | $205.4K5 Dec 31, 2024 | +11.7% |
| Property and equipment, net | $51.7K5 Dec 31, 2025 | $52.4K5 Dec 31, 2024 | −1.3% |
| Operating-lease assets (leased space) | $010 Dec 31, 2024 | $56.5K10 Dec 31, 2023 | −100.0% |
Real estate and locations
Investments
Properties, in its own words
On April 1, 2022, we moved office locations from 1201 Dove Street, Suite 300 in Newport Beach, California to 19800 MacArthur Boulevard, Suites 306 & 307, in Irvine, California, under a one-year lease. We renewed the lease on December 10, 2025, for an additional 12 months, with a new expiration of March 31, 2027. This office space now serves as our principal executive office, as well as the principal office of our operating subsidiaries. The new office space is for the executive team and shared office space for key employees to use as needed. We have decided to keep the majority of our workers remote, which gives us the flexibility to hire employees inside and outside of the state of California. We anticipate our new office space will be suitable and adequate for our needs for the duration of the lease. Our telephone number is 949-721-8272.
Item 2 of the 10-K filed Mar 18, 2026.4
Leadership
Who has led PACIFIC HEALTH CARE ORGANIZATION INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerTom Kubota Apr 12, 2012 to now14
- PresidentTom Kubota Mar 28, 2007 to now15
- Chief financial officerKristina Kubota Feb 12, 2021 to Feb 12, 202116
- Chief financial officerFrank R. Hough Apr 25, 2008 to Apr 25, 200817
- Chief financial officerFred U. Odaka Aug 18, 2008 to Mar 12, 201918
- Chief financial officerDonald Hellwig Feb 14, 2006 to Feb 14, 200619
Board members and other officers (7)
- Board memberKristina Kubota Feb 20, 2018 to Feb 12, 202120
- Board memberLauren Kubota Feb 20, 2018 to Feb 12, 202121
- Board memberGunter Soraperra Nov 18, 2016 to Nov 18, 201622
- Board memberStacy A. Hadley Nov 21, 2016 to Nov 21, 201623
- Board memberTom Kubota Mar 28, 2007 to now15
- Board memberDonald Hellwig Feb 14, 2006 to Feb 14, 200619
- Board memberThomas Iwanski Feb 14, 2006 to Feb 14, 200624
Timeline
- Sep 23, 20258-K Other events25
- Aug 13, 20258-K Executive or director change26
- Jul 16, 20258-K Executive or director change27
- Nov 7, 20248-K Change of auditor28
- Jan 5, 20248-K Executive or director change29
- Dec 22, 20238-K Change of auditor30
- May 31, 20238-K Other events31
- Apr 12, 2012New chief executive Tom Kubota becomes CEO14
Filings
68 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 7 major events, 31 insider forms, 5 large holders, 5 other. The latest 20:
- Aug 4, 202610-Q EDGAR
- Jun 4, 20264 EDGAR
- Jun 2, 2026SCHEDULE 13D/A EDGAR
- Jun 2, 20264 EDGAR
- Apr 30, 202610-Q EDGAR
- Mar 18, 202610-K EDGAR
- Nov 4, 202510-Q EDGAR
- Sep 23, 20258-K EDGAR
- Aug 13, 20258-K EDGAR
- Jul 31, 202510-Q EDGAR
- Jul 16, 20258-K EDGAR
- May 2, 202510-Q EDGAR
- Mar 19, 202510-K EDGAR
- Nov 7, 20248-K EDGAR
- Nov 1, 202410-Q EDGAR
- Aug 7, 202410-Q EDGAR
- Jun 28, 20244 EDGAR
- Jun 24, 20244 EDGAR
- Jun 7, 20244 EDGAR
- May 31, 20244 EDGAR
The 68 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
34 open-market trades by officers, directors and large owners since October 2021: 34 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | KUBOTA TOMCEO & President | Buy | 24,742 | $1.00 | $24.7K | Form 4 |
| May 27, 2026 | KUBOTA TOMCEO & President | Buy | 65,258 | $1.00 | $65.3K | Form 4 |
| Jun 26, 2024 | KUBOTA TOMCEO & President | Buy | 20,999 | $0.97 | $20.3K | Form 4 |
| Jun 24, 2024 | KUBOTA TOMCEO & President | Buy | 6,000 | $0.89 | $5.3K | Form 4 |
| Jun 20, 2024 | KUBOTA TOMCEO & President | Buy | 270 | $0.75 | $202 | Form 4 |
| Jun 6, 2024 | KUBOTA TOMCEO & President | Buy | 16,000 | $0.83 | $13.3K | Form 4 |
| May 31, 2024 | KUBOTA TOMCEO & President | Buy | 6,084 | $0.75 | $4.6K | Form 4 |
| May 28, 2024 | KUBOTA TOMCEO & President | Buy | 4,800 | $0.74 | $3.6K | Form 4 |
| May 24, 2024 | KUBOTA TOMCEO & President | Buy | 4,000 | $0.74 | $3.0K | Form 4 |
| May 21, 2024 | KUBOTA TOMCEO & President | Buy | 100 | $0.71 | $71 | Form 4 |
| May 16, 2024 | KUBOTA TOMCEO & President | Buy | 100 | $0.71 | $71 | Form 4 |
| Oct 2, 2023 | KUBOTA TOMCEO & President | Buy | 55,000 | $0.80 | $44.0K | Form 4 |
| Sep 27, 2023 | KUBOTA TOMCEO & President | Buy | 5,000 | $0.85 | $4.2K | Form 4 |
| Sep 26, 2023 | KUBOTA TOMCEO & President | Buy | 20,000 | $0.85 | $17.0K | Form 4 |
| Sep 22, 2023 | KUBOTA TOMCEO & President | Buy | 400 | $0.82 | $328 | Form 4 |
| Sep 12, 2023 | KUBOTA TOMCEO & President | Buy | 200 | $0.82 | $164 | Form 4 |
| Sep 11, 2023 | KUBOTA TOMCEO & President | Buy | 54,047 | $0.82 | $44.3K | Form 4 |
| Sep 7, 2023 | KUBOTA TOMCEO & President | Buy | 61,000 | $0.85 | $51.9K | Form 4 |
| Aug 30, 2023 | KUBOTA TOMCEO & President | Buy | 31,000 | $0.90 | $27.9K | Form 4 |
| Jun 20, 2023 | KUBOTA TOMCEO & President | Buy | 37,000 | $0.87 | $32.2K | Form 4 |
All 34 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Tom KubotaSCHEDULE 13D/A, 4 filings Dec 29, 2021 to Jun 2, 202632
- Bruce EverakesSC 13G, 1 filing Apr 12, 202333
SEC filer profile
How PACIFIC HEALTH CARE ORGANIZATION INC is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARPACIFIC HEALTH CARE ORGANIZATION INC1
- CIK0001138476
- Employer ID (EIN)87-02852384
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inUtah4
- Fiscal year endsDecember 311
- Industry code (SIC)8090 Services-Misc Health & Allied Services, NEC1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address19800 Macarthur Boulevard, Suites 306 & 307, Irvine, CA 926121
- Phone(949) 721-82721
- Shares outstanding12,800,000 as of Aug 4, 202612
- Public float$3.5M as of Jun 30, 20254
- AuditorBoulay PLLP, Minneapolis, Minnesota PCAOB ID 542; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceSep 19, 20021
- Filings336 in all: 4 (107), 10-Q (56), 8-K (36), SC 13D/A (22), 10-K (18), 10QSB (15), 3 (11), CORRESP (9)1
All 30 form types
NT 10-Q (8), 10KSB (6), NT 10-K (6), UPLOAD (6), 5 (5), DEF 14A (5), SC 13G (5), 10SB12G/A (3), 4/A (2), DEF 14C (2), PRE 14C (2), SC 13D (2), 10-Q/A (1), 10KSB/A (1), 10SB12G (1), 8-K/A (1), NT 10-Q/A (1), PRE 14A (1), S-8 (1), S-8 POS (1), SC 13G/A (1), SCHEDULE 13D/A (1)
- Latest filingsAnnual report (10-K) Mar 18, 2026
Quarterly report (10-Q) Aug 4, 2026
Proxy statement (DEF 14A) Mar 13, 2008
Latest 8-K (8-K) Sep 23, 2025
Risk factors and legal proceedings
The risks PACIFIC HEALTH CARE ORGANIZATION INC names in Item 1A of its 10-K filed Mar 18, 2026: 27 risks under these headings, as written.4
- You should not draw any inference as to the magnitude or likelihood of any particular risk from its position or categorization in the following discussion. Further, the headings and subheadings of the risk factors are organized based on certain shared characteristics with other risk factors, but each risk factor should be read without limiting its application or content to the heading under which it is organized.
- Customer, Vendor and Competition Related Risks
- A significant percentage of our revenue is generated from a few customers, the loss of one or more of which could have a material impact on our results of operations, cash flows and financial condition.
- A significant percentage of our accounts receivable is generated from a few customers, and if one or more of these customers default on their payment obligations to us, it could have a material impact on our results of operations, cash flows and financial condition.
- We are reliant on the timely, accurate and consistent provision of outsourced services for various services and business functions, the disruption, malfunction, termination or replacement of which could impede our ability to provide our services and materially adversely affect our business.
- Our revenues may decline if we cannot compete successfully in an intensely competitive market.
- If the scope and quality of our services lag behind the market or lower costs can be obtained elsewhere, we may lose customers which could have a material adverse impact on our results of operations and financial condition.
- If we are unable to attract and retain employees and consultants with the skills our business requires, our business operations could be impacted negatively.
- Cybersecurity, Information Technology and Outsourced Services Related Risks
- A cybersecurity breach or other disruption to our or our vendors’ information technology systems could result in the loss, theft, misuse, unauthorized disclosure of, or unauthorized access to customer, customer-employee or company information, or could otherwise disrupt our operations, any of which could materially adversely affect our business, financial condition or results of operations.
- We cannot assure that we can maintain cyber liability insurance coverage and we could be subject to uninsured liabilities.
- Our financial performance is tied to the availability, quality and functionality of the information technology platforms we can acquire or license from third parties to provide our services, the loss of which could disrupt our business and ability to remain competitive.
The other 17 risks
- The adoption, use, and reliability of disruptive technologies such as artificial intelligence technology (“AI”), and the continued rapid pace of development of such technologies, are inherently uncertain and present risks that could have a material adverse effect on our business and results of operations.
- An interruption in our ability to access, review or deliver data may cause customers to terminate our services and/or may reduce our ability to effectively compete.
- If we are unable to safeguard the security and privacy of confidential data, including personal information of our customers and their employees, or comply with applicable data privacy laws, our reputation and business could be harmed.
- Licensure and Regulatory Risks
- Failure to maintain our licenses and/or accreditation would have a material, adverse impact on our business and results of operations.
- Changes in government regulations may negatively impact our costs of operation and/or demand for our services.
- Industry Trend Related Risks
- Challenges to the use of certain healthcare cost containment techniques may cause our revenue to decrease.
- Increased use of early intervention services could negatively impact our revenue.
- Declines in workers’ compensation claims could materially impact our financial condition and results of operations.
- Risks Related to Owning our Securities
- The price and trading volume of our common stock may be volatile, which may negatively affect its value and liquidity.
- Our Chief Executive Officer, President and Chairman of the board of directors has the ability to exercise significant control over the Company.
- General Risk Factors
- Restrictions on immigration or changes in immigration laws, policy, or enforcement, could have adverse impacts on our condition and the condition of our customers and their workforces, and the healthcare industry, which could have an adverse impact on our results of operations and financial condition.
- U.S. trade policies and retaliatory responses from other countries may adversely impact our customers’ businesses and result in a reduction or elimination of our services.
- Even if we are successful in making strategic acquisitions, it could have a negative impact on our business.
- Litigation and legal liability may adversely affect our financial condition and results of operations.
- The effects of inflation may have a disproportionate impact on our business.
- A partial or full shutdown of the U.S. federal government resulting from a failure to enact spending authorization or appropriations legislation may adversely affect our business.
- Acts of war, terrorist attacks, natural disasters, and health crises (including epidemics and pandemics), may harm our business, operating results, and financial condition.
Legal proceedings
For information regarding legal proceedings, see “Note 11 – COMMITMENTS AND CONTINGENCIES” of Part II, Item 8 Notes to Consolidated Financial Statements, which discussion we incorporate by reference into this Item.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARTom Kubota, Chief executive officer
- 15SEC EDGARTom Kubota, President
- 16
- 17
- 18
- 19
- 20SEC EDGARKristina Kubota, Board member
- 21SEC EDGARLauren Kubota, Board member
- 22SEC EDGARGunter Soraperra, Board member
- 23SEC EDGARStacy A. Hadley, Board member
- 24SEC EDGARThomas Iwanski, Board member
- 25SEC EDGAROther events
- 26SEC EDGARExecutive or director change
- 27SEC EDGARExecutive or director change
- 28SEC EDGARChange of auditor
- 29SEC EDGARExecutive or director change
- 30SEC EDGARChange of auditor
- 31SEC EDGAROther events
- 32
- 33